722 research outputs found
Polysaccharides and polyphenols in sea buckthorn leaf tea have synergistic impact on studied colonic strains in vitro and bacteria in vivo
Present research on prebiotics focuses on either polysaccharides or polyphenols. This study compared the individual and combined impact of polysaccharide, quercetin, and gallic acid (GA) treatment on three human faecal strains. In vitro pure culturing and correlation analysis confirmed that the growth of both beneficial microbe B. longum subsp. longum (0.695, 0.205: R2, slope, respectively) and pathogenic C. perfringens (0.712, 0.085: R2, slope, respectively) increased due to polysaccharide treatment, and only GA treatment would inhibit C. perfringens (0.789, â0.165: R2, slope, respectively) growth. In vivo studies also revealed that genome copies of Bifidobacterium increased and C. perfringens decreased in the faeces, when a blend of the three nutrients rather than single polysaccharide or polyphenols were fed to rats. These data suggested that combined prebiotic treatment improved human faecal strain composition better than single treatment
Pair production of charged Higgs bosons in the Left-Right Twin Higgs model at the ILC and LHC
Left-Right twin Higgs(LRTH) model predicts the existence of a pair of charged
Higgs . In this paper, we study the production of the charged Higgs
bosons pair via the process at
the International Linear Collider(ILC). The numerical results show that the
production rates are at the level of several tens fb, this process can produce
the adequate distinct multi-jet final states and the SM background can be
efficiently reduced. We also discuss the charged Higgs boson pair production
via the process at the Large Hadron
Collider(LHC) and estimate there production rates. We find that, as long as the
charged Higgs bosons are not too heavy, they can be abundantly produced at the
LHC. The possible signatures of these new particles might be detected at the
ILC and LHC experiments.Comment: 15 pages, 5 figures, discussion extended, reference added, typos
fixed, revised version to be published in Eur.Phys.J.
Precise Determination of Proton Spin-Precession Angles in the K600 Spectrometer and Beamline
This research was sponsored by the National Science Foundation Grant NSF PHY-931478
A Complete Set of In-plane Spin-transfer Coefficients for Small Angle pp Elastic Scattering at 200 MeV
This research was sponsored by the National Science Foundation Grant NSF PHY-931478
Azonexus hydrophilus sp nov., a nifH gene-harbouring bacterium isolated from freshwater
Three Gram-negative, non-pigmented, rod-shaped, facultatively aerobic bacterial strains, designated d8-1(T), d8-2 and IMCC1716, were isolated from a freshwater spring sample and a eutrophic freshwater pond. Based on characterization using a polyphasic approach, the three strains showed highly similar phenotypic, physiological and genetic characteristics. All of the strains harboured the nitrogenase gene nifH, but nitrogen-fixing activities could not be detected in nitrogen-free culture media. The three strains shared 99.6-99.7 % 16S rRNA gene sequence similarity and showed 89-100 % DNA-DNA relatedness, suggesting that they represent a single genomic species. Phylogenetic analysis based on 16S rRNA gene sequences showed that strains d8-1(T), d8-2 and IMCC1716 formed a monophyletic branch in the periphery of the evolutionary radiation occupied by the genus Azonexus. Their closest neighbours; were Azonexus caeni Slu-05(T) (96.7-96.8% similarity) and Azonexus fungiphilus BS5-8(T) (96.3-96.6 %). The DNA-DNA relatedness of the novel strains to these two species of the genus Azonexus was less than 70%. The isolates could also be differentiated from recognized members of the genus Azonexus on the basis of phenotypic and biochemical characteristics. It is evident, therefore, that the three strains represent a novel species of the genus Azonexus, for which the name Azonexus hydrophilus sp. nov. is proposed. The type strain is d8-1(T) (=LMG 24005(T)=BCRC 17657 (T))
Periodic and Quasiperiodic Motion of an Elongated Microswimmer in Poiseuille Flow
We study the dynamics of a prolate spheroidal microswimmer in Poiseuille flow
for different flow geometries. When moving between two parallel plates or in a
cylindrical microchannel, the swimmer performs either periodic swinging or
periodic tumbling motion. Although the trajectories of spherical and elongated
swimmers are qualitatively similar, the swinging and tumbling frequency
strongly depends on the aspect ratio of the swimmer. In channels with reduced
symmetry the swimmers perform quasiperiodic motion which we demonstrate
explicitely for swimming in a channel with elliptical cross section
A Quantitative Model of Energy Release and Heating by Time-dependent, Localized Reconnection in a Flare with a Thermal Loop-top X-ray Source
We present a quantitative model of the magnetic energy stored and then
released through magnetic reconnection for a flare on 26 Feb 2004. This flare,
well observed by RHESSI and TRACE, shows evidence of non-thermal electrons only
for a brief, early phase. Throughout the main period of energy release there is
a super-hot (T>30 MK) plasma emitting thermal bremsstrahlung atop the flare
loops. Our model describes the heating and compression of such a source by
localized, transient magnetic reconnection. It is a three-dimensional
generalization of the Petschek model whereby Alfven-speed retraction following
reconnection drives supersonic inflows parallel to the field lines, which form
shocks heating, compressing, and confining a loop-top plasma plug. The
confining inflows provide longer life than a freely-expanding or
conductively-cooling plasma of similar size and temperature. Superposition of
successive transient episodes of localized reconnection across a current sheet
produces an apparently persistent, localized source of high-temperature
emission. The temperature of the source decreases smoothly on a time scale
consistent with observations, far longer than the cooling time of a single
plug. Built from a disordered collection of small plugs, the source need not
have the coherent jet-like structure predicted by steady-state reconnection
models. This new model predicts temperatures and emission measure consistent
with the observations of 26 Feb 2004. Furthermore, the total energy released by
the flare is found to be roughly consistent with that predicted by the model.
Only a small fraction of the energy released appears in the super-hot source at
any one time, but roughly a quarter of the flare energy is thermalized by the
reconnection shocks over the course of the flare. All energy is presumed to
ultimately appear in the lower-temperature T<20 MK, post-flare loops
\psi(2S) Decays into \J plus Two Photons
Using \gamma \gamma J/\psi, J/\psi \ra e^+ e^- and events
from a sample of \psip decays collected with the BESII
detector, the branching fractions for \psip\ra \pi^0\J, \eta\J, and
\psi(2S)\ar\gamma\chi_{c1},\gamma\chi_{c2}\ar\gamma\gamma\jpsi are measured
to be B(\psip\ra \pi^0\J) = (1.43\pm0.14\pm0.13)\times 10^{-3}, B(\psip\ra
\eta\J) = (2.98\pm0.09\pm0.23)%,
B(\psi(2S)\ar\gamma\chi_{c1}\ar\gamma\gamma\jpsi) = (2.81\pm0.05\pm 0.23)%,
and B(\psi(2S)\ar\gamma\chi_{c2}\ar\gamma\gamma\jpsi) = (1.62\pm0.04\pm
0.12)%.Comment: 7 pages, 6 figures. submitted to Phys. Rev.
Limits on anomalous trilinear gauge boson couplings from WW, WZ and Wgamma production in pp-bar collisions at sqrt{s}=1.96 TeV
We present final searches of the anomalous gammaWW and ZWW trilinear gauge
boson couplings from WW and WZ production using lepton plus dijet final states
and a combination with results from Wgamma, WW, and WZ production with leptonic
final states. The analyzed data correspond to up to 8.6/fb of integrated
luminosity collected by the D0 detector in pp-bar collisions at sqrt{s}=1.96
TeV. We set the most stringent limits at a hadron collider to date assuming two
different relations between the anomalous coupling parameters
Delta\kappa_\gamma, lambda, and Delta g_1^Z for a cutoff energy scale Lambda=2
TeV. The combined 68% C.L. limits are -0.057<Delta\kappa_\gamma<0.154,
-0.015<lambda<0.028, and -0.008<Delta g_1^Z<0.054 for the LEP parameterization,
and -0.007<Delta\kappa<0.081 and -0.017<lambda<0.028 for the equal couplings
parameterization. We also present the most stringent limits of the W boson
magnetic dipole and electric quadrupole moments.Comment: 10 pages, 5 figures, submitted to PL
Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition
Selenium supplement has been shown in clinical trials to reduce the risk of different cancers including lung carcinoma. Previous studies reported that the antiproliferative and pro-apoptotic activities of methylseleninic acid (MSA) in cancer cells could be mediated by inhibition of the PI3K pathway. A better understanding of the downstream cellular targets of MSA will provide information on its mechanism of action and will help to optimize its use in combination therapies with PI3K inhibitors. For this study, the effects of MSA on viability, cell cycle, metabolism, apoptosis, protein and mRNA expression, and reactive oxygen species production were analysed in A549 cells. FOXO3a subcellular localization was examined in A549 cells and in stably transfected human osteosarcoma U2foxRELOC cells. Our results demonstrate that MSA induces FOXO3a nuclear translocation in A549 cells and in U2OS cells that stably express GFP-FOXO3a. Interestingly, sodium selenite, another selenium compound, did not induce any significant effects on FOXO3a translocation despite inducing apoptosis. Single strand break of DNA, disruption of tumour cell metabolic adaptations, decrease in ROS production, and cell cycle arrest in G1 accompanied by induction of apoptosis are late events occurring after 24h of MSA treatment in A549 cells. Our findings suggest that FOXO3a is a relevant mediator of the antiproliferative effects of MSA. This new evidence on the mechanistic action of MSA can open new avenues in exploiting its antitumour properties and in the optimal design of novel combination therapies. We present MSA as a promising chemotherapeutic agent with synergistic antiproliferative effects with cisplatin. (C) 2015 Elsevier Ltd. All rights reserved.Ministerio de Ciencia e Innovacion, Spain [SAF2011-25726]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya [2014SGR1017]; Ministerio de Economia y Competitividad, Spain [SAF2014-56059-R]; Fundacao para a Ciencia e a Tecnologia (FCT) Research Center [UID/BIM/04773/2013CBMR 1334]; National Institute of Health, USA [1R01CA118434-01A2, 1P01CA163223-01A1]; National Science Foundation, USA [EPS-0447479]; FCT [SFRH/BPD/84634/2012]; prize ICREA Academia for excellence in research; ICREA Foundation-Generalitat de Cataluny
- âŠ